Pharmacy Podcast Network - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

Pharmacy Podcast Network — Business
Pharmacy Podcast Network

Pharmacy Podcast Network (PPN) is the world’s largest network of podcasts dedicated to the pharmacy professional and industry insiders. Our content is about dynamic people in the pharmacy industry making a difference and delivering the best pharmacy care. We have over 40+ podcasts with thousands of interviews.

Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care.

Join the home of the O.G. Pharmacy Podcast & discover our newest development: Evidence-based Podcasting, the first CME supplement in podcast form that’s truly peer-reviewed. The future of podcasting education for Providers is “Evidence-based Podcasting” (TM) and we’re building a peer-review board, reach out to us: Publisher @ Pharmacy Podcast dot com.

PPN is a division of RxPR, LLC. Copyright 2026

Latest Episodes:

Not All Heroes Wear Capes | Beyond the Sig Apr 09, 2021

Show notes

Skippack Pharmacy has been leading mass COVID-19 vaccination efforts in the Schwenksville, Pennsylvania community and their efforts have gained national attention. You might recognize Skippack’s owner as the Superman pharmacist recently featured on Good Morning America. Today, we will hear from two members of the Skippack team, who have been working behind the scenes to help Skippack Pharmacy administer over 10,000 COVID-19 vaccines. On this episode of Beyond the Sig, third-year student pharmacist Brooke Kulusich chats with Skippack Pharmacy intern, Erica Mabry, and American Pharmacists Association (APhA) Chief of Governance & State Affiliates and Executive Director of the APhA Foundation, Mitch Rotholz, who is the policy lead for immunizations for the profession. They share their experiences working together to coordinate these clinics and their perspectives on the future of community pharmacy practice transformation. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

A Story of Innovation in Health System Pharmacy (01) | Allegheny Health Network Apr 09, 2021

Show notes

Chapter 1 of 3 Featuring: Allegheny Health Network Pharmacy Services AHN overview and history AHN Pharmacy Transformation – Patient – centered care planning Becoming one team Standardized practice / technology throughout all sites Guests: Laura (McCoy) Mark, PharmD - Vice President, Pharmacy Arpit Mehta, Pharm.D., MPH, MHA - Director of Pharmacy Kelley Wasicek, BS Pharm Director of Pharmacy Rob Simpson, PharmD This podcast series is sponsored by Omnicell. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Cannabis Industry Election Victories | CRx Podcast Apr 09, 2021

Show notes

The cannabis industry won at the ballot box in the recent election, with four states passing laws to make cannabis legal for adults and two approving cannabis for medical purposes. These results moved the National Cannabis Industry Association (NCIA) closer to its goal of building a robust cannabis industry while supporting state laws and advocating for federal policy reforms. On November 3, 2020, voters in five states made a definitive statement about cannabis use. Arizona, Montana, New Jersey, and South Dakota approved adult use of cannabis. South Dakota also approved a medical initiative, along with Mississippi, which approved comprehensive cannabis medical options. The National Cannabis Industry Association (NCIA) has been working toward outcomes such as these since 2010. With 2,000 members nationwide, the organization is supporting the industry as cannabis becomes a thriving business and a real economic force. In recent years, NCIA has been a vocal advocate for social equity, working to promote expungement of criminal records of many people—largely from minority communities—who were unfairly incarcerated as part of the ill-conceived War on Drugs. The results of the initiatives in these five states illustrate how far the industry has come. The people have spoken, and their voice was definitive. “The margins were higher than we expected,” says Morgan Fox, spokesperson for NCIA. “In Arizona, there was a 60% margin, while the margin in New Jersey was 66%, 10 points higher than it was in California when it passed an adult use initiative in 2016. These results are not just political victories; they will likely have widespread ramifications. Importantly, it will be much more difficult for law enforcement to use cannabis as a weapon against minority populations. Instead, we will likely see more economic opportunities in the industry and fewer arrests overall.” Although there were differences among the measures passed, those that supported legalization all set 21 as the legal age for use. In New Jersey, the law requires that the state set a regulatory structure, along with limits for possession and homegrown cannabis plants. Arizona established the number of plants allowed at six, while South Dakota limited cultivation to three. The law in Arizona also stated that the Department of Health Services must promote business ownership and industry participation among people from communities who have been harmed by former cannabis policies. Furthermore, a portion of cannabis tax revenue will be set aside for the newly created Justice Reinvestment Fund. To date, almost 34% of Americans live in states with laws establishing cannabis as legal and regulated for adults. Four of the five states that recently passed laws legalizing cannabis have been responsible for roughly 60,000 cannabis arrests each year, mostly for simple possession. On the economic side, researchers estimate that the combined value of the cannabis markets in these five states will climb to more than $3.1 billion by 2025. In states where cannabis is now legal, Congressional representation will increase by 29 representatives and eight senators. In sum, cannabis is now legal for adults in 15 states, as well as the District of Columbia and the territories of CNMI and Guam. What’s more, 36 states and several territories have comprehensive medical cannabis laws. Cannabis is now legal in some form in 47 states in the United States. Guests: David L. Nathan, MD, DFAPA President, Board of Directors Doctors for Cannabis Regulation Abby Stoddard, PharmD, MBA The Client Centered Network www.clientcn.com See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Cancer Pain Conundrum | CRx Podcast Apr 08, 2021

Show notes

Opioids play a critical role in managing cancer-associated pain, but they’re highly addictive, and they don’t always provide sufficient pain relief for cancer patients. Many patients therefore turn to cannabis or cannabis-derived products to help manage their pain, using them either as standalone treatments or as an adjuvant therapy to opioids. But does research support cannabis use for this purpose? The evidence is mixed, and some studies suggest there may indeed be benefits for cancer pain—but there’s also reason for caution. How Much Research Is There? There’s a relatively strong body of research on cannabis for the treatment of chronic pain generally, according to Eloise Theisen, RN, MSN, president of the American Cannabis Nurses Association and co-founder of Radicle Health, a cannabis education and advocacy organization. However, much of this research has focused on neuropathic pain in multiple sclerosis and spinal cord injuries, and comparatively few studies have examined pain in the cancer context. Among the studies that exist for cancer, many have small sample sizes, and study design is also an issue. “We have animal studies and some clinical human studies,” says Theisen, but there’s “a lack of randomized controlled trials, which are considered to be the gold standard.” A further complicating factor in the research on cannabis and cancer pain is that most of the existing studies on this topic have relied on products that do not match those cancer patients actually use in practice. According to Hance Clarke, MD, PhD, associate professor of anesthesia at the University of Toronto and author of a recent review article on cannabis and pain,1 the products that have been studied most extensively are pharmaceutical-grade cannabis isolates, such as nabiximols (an extract containing THC and CBD in a precise one-to-one ratio), nabilone (synthetic THC), and dronabinol (also synthetic THC). However, cancer patients outside of the research context are much more likely to use dispensary cannabis and non-pharmaceutical-grade plant-based extracts. “We’re kind of stuck without enough evidence on the products that people are currently using,” says Clarke. This is important, because patients may react quite differently to a dispensary product than to a pharmaceutical product, according to Clarke. Guests: Eloise Theisen, MSN, RN, is a board certified Adult Geriatric Nurse Practitioner who specializes in cannabis therapy. For over 20 years, Eloise has worked primarily with cancer, dementia and chronic pain patients. In the last several years, Eloise has focused her efforts on cannabinoid therapies. Eloise was one of the first healthcare professionals to bring a clinical dosing regimen to the cannabis space. In 2019, Eloise was elected President of the American Cannabis Nurses Association and will serve through 2022. In 2019, Eloise co-authored Pain Free with CBD: Everything You Need to Know and Effectively Use Cannabidiol with Alice O’Leary Randall. Joe Jeffries, Pharm D is currently Director of Pharmacy at FarmaceuticalRx, a medical cannabis dispensary in East Liverpool Ohio. Joe is the former Director of Pharmacy at Barnesville Hospital and was named the Healthcare Worker of the Year, largely for his creation of a program to help those struggling with drug addiction. Joe was also President of the Ohio Pharmacists Association from 2000-2001. Host: Joseph Friedman CannaRPh Consultants CRx Magazine Advisory Board, CRx Podcast See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Clinical Implications & Application of Pharmacogenomics | PGX for Pharmacists Apr 07, 2021

Show notes

Behnaz Sarrami, MS, PharmD, a PGx for pharmacists podcast, joins Cari Lalande, PharmD where we discuss the clinical value and utility of PGx and how it can be implemented in a clinical setting. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Don’t Stop Me Now | GameChangers Apr 06, 2021

Show notes

The battle against the COVID-19 pandemic has continued for over a year. The evidence continues to update and change, and more and more people are becoming vaccinated. This episode provides a review of the newest literature including guidance on vaccinated individuals. But, remember, don't stop wearing a mask now! Reference: Interim Public Health Recommendations for Fully Vaccinated People. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated-guidance.html. CPE details for GameChangers Podcast April 2021 Learning Objective: Describe evidence-based recommendations to mitigate SARS-CoV-2 infections 0107-0000-21-158-H01-P 0.2 CEU/2 Hrs (Knowledge) Initial Release Date: 04/06/21 Expiration Date: 03/02/24 Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Commitment to Evidence Based Content Development | Bernadette Mazurek Melnyk PhD Apr 05, 2021

Show notes

Fascinating discussion with the Ohio State University's Chief Wellness Officer & author of Evidence-based Competencies in Healthcare, Dr. Bernadette Melnyk PhD about evidence-based practice of medicine and raising the standards of content development. Hospitals and healthcare systems around the world have attempted to build and sustain evidence-based practice (EBP) cultures and environments, yet they have struggled to clearly understand what EBP competency means. Implementing the Evidence-Based Practice (EBP) Competencies in Healthcare clears up that confusion and serves as a guide for clinicians, leaders, faculty, EBP mentors, and students in achieving EBP competency, facilitating evidence-based decision making in daily practice, and accelerating the speed at which research knowledge is translated into real-world settings to improve health outcomes and decrease healthcare costs. We must develop content which is clinically focused in the same manner as practicing Evidence-based medicine. Implementing the Evidence-based Practice (EBP) Competencies in HealthcareA Practical Guide to Improving Quality, Safety, and Outcomes By Bernadette Mazurek Melnyk, Lynn Gallagher-Ford, Ellen Fineout-Overholt Bernadette Mazurek Melnyk, PhD, RN, CPNP/PMHNP, FAANP, FNAP, FAAN, is Associate Vice President for Health Promotion, University Chief Wellness Officer, and Professor and Dean of the College of Nursing at The Ohio State University (OSU) and Professor at OSU's College of Medicine. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

National Patient Counseling Competition | Future Pharmacy Leaders Apr 03, 2021

Show notes

Deanna J. Schnitzer is a pharmacy student the University of Pittsburgh School of Pharmacy. Deanna was a finalist for the National Patient Counseling Competition. The goal of the APhA-ASP National Patient Counseling Competition is to encourage student pharmacists in their efforts toward becoming better patient educators. 2021 National Patient Counseling Competition FINALISTS Anna Brown – University of North Carolina at Chapel Hill Amy Chan – Virginia Commonwealth University Sara Salama – Midwestern University, Downers Grove Campus Deanna Schnitzer – University of Pittsburgh Tammy Nguyen – The University of Kansas Isabelle Tharp – Drake University Madison Wiarek – University of Wisconsin – Madison Alison Weygint – The University of Arizona Allison Vu – University of California, San Diego This episode is sponsored by the Ultiguard Safe Pack. UltiGuard Safe Pack is the only pen needle product that comes with an all-in-one sharps container. Learn more about why UltiGuard Safe Pack is the best choice for your patients and your pharmacy., Learn more about the UltiGuard Safe Pack: https://www.ulticare.com/ultiguard-safe-pack/podcast See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacogenomics Rotation of Pharmacy Students | PGx for Pharmacists Apr 02, 2021

Show notes

Behnaz Sarrami, MS, PharmD, a PGx for pharmacists podcast, Maci Koesterer, PharmD candidate 2021 from St. Louis College of Pharmacy where we discuss her first virtual and unique rotation in PGx and her recommendations to other students. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Thinking Outside the Box | PGx for Pharmacists Apr 01, 2021

Show notes

Behnaz Sarrami, MS, PharmD, an entrepreneur and a coach in PGx who has started her own consulting business bringing awareness to the clinical value and utility of PGx to providers, pharmacists, and consumers. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Related Podcasts